ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 175630 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 175630; 2) Community: the network communities that were significantly associated with the response to NSC 175630; 3) Molecule: the relationships between components within communities and NSC 175630; 4) MDR: the compounds that were significantly associated with the NSC 175630.

NSC Compound Enrichment Correlation
NSC 756304 GW678313X 0.00707875925191925 -0.26724043
NSC 756698 Clomiphene citrate (USAN) 0.00707875925191925 0.2007573
NSC 678932 1H-Benzimidazole-4-carboxamide, N-[2-(dimethylamino)ethyl]-2-(4-pyridinyl)-, hydrochloride 0.00744479268267742 0.29265628
NSC 720255 Null 0.00744479268267742 0.30324188
NSC 673104 Null 0.00747047727028992 -0.26935418
NSC 681750 Null 0.00747047727028992 -0.35401809
NSC 221266 Benzoic acid, 3,4-dichloro-, [1-[4-[(3-amino-2,3,6-trideoxy-.alpha.-L-lyxo-hexopyranosyl)oxy]-1,2,3,4,6,11-hexahydro-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-2-naphthacenyl]ethylidene]hydrazide, monohy 0.00845932736945076 0.25504896
NSC 281383 Null 0.00845932736945076 0.40627147
NSC 629736 Null 0.00845932736945076 0.22806112
NSC 683662 2-Azabicyclo[16.3.1]docosa-1(21),4,6,10,18-pentaene- 3,20,22-trione, 9-[[(amino)carbonyl]oxy]-8,14-dimethoxy- 4,10,12,16-tetramethyl-13-[2-(dimethylamino)-1-oxoethoxy]-19-[(2-propenyl)amino]-, stereo 0.00845932736945076 0.14538923
Total:58  Current:10    [First] [Prev] [Next] [Last]